abstract |
The present invention relates to Robo1-Fc recombinant protein and its use for the treatment of diseases, in particular cancer, in which the Slit protein is overexpressed. The invention also relates to a composition comprising such recombinant protein. Another aspect of the invention involves the use of Robo1-Fc molecules as a diagnostic tool for detecting overexpression of molecules belonging to the slit family in a patient. |